Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Breast Cancer

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 103 articles:
HTML format



Single Articles


    November 2020
  1. ZHANG JQ, Plitas G
    Immunotherapeutic strategies in breast cancer: A clinical update.
    J Surg Oncol. 2020 Nov 6. doi: 10.1002/jso.26287.
    PubMed     Abstract available


    October 2020
  2. SUTTON TL, Schlitt A, Gardiner SK, Johnson N, et al
    Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.
    J Surg Oncol. 2020 Oct 30. doi: 10.1002/jso.26216.
    PubMed     Abstract available


  3. LI X, Tan Q, Li H, Yang X, et al
    Predictive value of tumor-infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis.
    J Surg Oncol. 2020 Oct 12. doi: 10.1002/jso.26252.
    PubMed     Abstract available


  4. CORSO G, Frassoni S, Girardi A, De Camilli E, et al
    Metaplastic breast cancer: Prognostic and therapeutic considerations.
    J Surg Oncol. 2020 Oct 12. doi: 10.1002/jso.26248.
    PubMed     Abstract available


  5. ESGUEVA A, Siso C, Espinosa-Bravo M, Sobrido C, et al
    Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments.
    J Surg Oncol. 2020 Oct 1. doi: 10.1002/jso.26236.
    PubMed     Abstract available


    September 2020
  6. LEITE FPM, Curi C, Sanches SM, Curado MP, et al
    How to maintain elective treatment of breast cancer during the COVID-19 pandemic-A cancer center experience.
    J Surg Oncol. 2020 Sep 28. doi: 10.1002/jso.26233.
    PubMed    


  7. SINDONI A, Di Maria A, Fama' F
    Orbital metastases in infiltrating lobular carcinoma of the breast.
    J Surg Oncol. 2020;122:569.
    PubMed    


  8. AL-ARNAWOOT B, Scaranelo A, Fleming R, Kulkarni S, et al
    Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?
    J Surg Oncol. 2020;122:382-387.
    PubMed     Abstract available


    August 2020
  9. BERGER JM, Longhitano Y, Zanza C, Sener SF, et al
    Factors affecting the incidence of chronic pain following breast cancer surgery: Preoperative history, anesthetic management, and surgical technique.
    J Surg Oncol. 2020 Aug 19. doi: 10.1002/jso.26176.
    PubMed     Abstract available


  10. CAVALCANTE FP, Novita GG, Millen EC, Zerwes FP, et al
    Breast cancer and COVID-19 pandemic in Brazil.
    J Surg Oncol. 2020 Aug 5. doi: 10.1002/jso.26143.
    PubMed    


  11. SPAUTZ CC, Schunemann Junior E, Budel LR, Cavalcanti TCS, et al
    Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary staging.
    J Surg Oncol. 2020;122:164-169.
    PubMed     Abstract available


    July 2020
  12. BERGMANN A, Baiocchi JMT, de Andrade MFC, Thuler LCS, et al
    Comment to "Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort".
    J Surg Oncol. 2020 Jul 22. doi: 10.1002/jso.26094.
    PubMed    


  13. BRUNELLE CL, Roberts SA, Shui AM, Gillespie TC, et al
    Reply to: Bergmann et al comment to "Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort".
    J Surg Oncol. 2020 Jul 22. doi: 10.1002/jso.26132.
    PubMed    


  14. FRASSON AL, Resende HM, Lichtenfels M, Barbosa F, et al
    Axillary management for patients with breast cancer after neoadjuvant chemotherapy: Results of a survey among Brazilian breast surgeons.
    J Surg Oncol. 2020 Jul 7. doi: 10.1002/jso.26104.
    PubMed     Abstract available


  15. KOPKASH K, Sisco M, Poli E, Seth A, et al
    The modern approach to the nipple-sparing mastectomy.
    J Surg Oncol. 2020;122:29-35.
    PubMed     Abstract available


  16. BOLAND MR, Ryan EJ, Nugent T, Gilroy D, et al
    Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer patients.
    J Surg Oncol. 2020 Jul 1. doi: 10.1002/jso.26096.
    PubMed     Abstract available


    June 2020
  17. HAMMOND JB, Parnall TH, Scott DW, Kosiorek HE, et al
    Gauging the efficacy of neoadjuvant endocrine therapy in breast cancer patients with known axillary disease.
    J Surg Oncol. 2020 Jun 7. doi: 10.1002/jso.26047.
    PubMed     Abstract available


  18. JAKUBOWSKI DM, Bailey H, Abran J, Blacklock A, et al
    Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test.
    J Surg Oncol. 2020 Jun 4. doi: 10.1002/jso.26050.
    PubMed     Abstract available


  19. BRUNELLE CL, Roberts SA, Shui AM, Gillespie TC, et al
    Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
    J Surg Oncol. 2020 Jun 4. doi: 10.1002/jso.25944.
    PubMed     Abstract available


  20. JIANG Z, Yin J
    Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions.
    J Surg Oncol. 2020;121:1181-1190.
    PubMed     Abstract available


    May 2020
  21. ALTUNDAG K
    Orbital metastases in breast cancer patients with invasive lobular carcinoma.
    J Surg Oncol. 2020 May 24. doi: 10.1002/jso.26042.
    PubMed    


  22. CHENG M, Zhuang X, Zhang L, Zhu T, et al
    A nomogram to predict non-sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy.
    J Surg Oncol. 2020 May 20. doi: 10.1002/jso.25989.
    PubMed     Abstract available


  23. RESENDE PAULINELLI R, de Oliveira VM, Bagnoli F, Letzkus Berrios J, et al
    Oncoplastic mammaplasty with geometric compensation: Evolution of the technique, outcomes and follow-up in a multicentre retrospective cohort.
    J Surg Oncol. 2020;121:967-974.
    PubMed     Abstract available


    April 2020
  24. AHMED S, Pati S, Le D, Haider K, et al
    The prognostic and predictive role of 21-gene recurrence scores in hormone receptor-positive early-stage breast cancer.
    J Surg Oncol. 2020 Apr 28. doi: 10.1002/jso.25952.
    PubMed     Abstract available


  25. LADD MK, Peshkin BN, Isaacs C, Hooker G, et al
    Predictors of genetic testing uptake in newly diagnosed breast cancer patients.
    J Surg Oncol. 2020 Apr 28. doi: 10.1002/jso.25956.
    PubMed     Abstract available


  26. BHUTIANI N, Egger ME, Stromberg AJ, Bhutiani IK, et al
    Identifying factors impacting the efficacy of postmastectomy radiotherapy in patients with early-stage breast cancer and one to two positive lymph nodes.
    J Surg Oncol. 2020 Apr 25. doi: 10.1002/jso.25947.
    PubMed     Abstract available


  27. SINDONI A, Fama' F, Vinciguerra P, Dionigi G, et al
    Orbital metastases from breast cancer: A single institution case series.
    J Surg Oncol. 2020 Apr 15. doi: 10.1002/jso.25927.
    PubMed     Abstract available


    March 2020
  28. BHUTIANI N, Hicks AC, Huang B, Chen Q, et al
    Identifying factors influencing delays in breast cancer treatment in Kentucky following the 2014 Medicaid expansion.
    J Surg Oncol. 2020 Mar 29. doi: 10.1002/jso.25914.
    PubMed     Abstract available


  29. SQUITIERI L, Rasmussen PW, Patel KM
    An economic analysis of prophylactic lymphovenous anastomosis among breast cancer patients receiving mastectomy with axillary lymph node dissection.
    J Surg Oncol. 2020 Mar 23. doi: 10.1002/jso.25902.
    PubMed     Abstract available


  30. WECSLER J, Jeong YJ, Raghavendra AS, Mack WJ, et al
    Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers.
    J Surg Oncol. 2020;121:589-598.
    PubMed     Abstract available


    February 2020
  31. JIANG L, Liu T, Wang X, Li J, et al
    Real-time near-infrared fluorescence imaging mediated by blue dye in breast cancer patients.
    J Surg Oncol. 2020 Feb 26. doi: 10.1002/jso.25874.
    PubMed     Abstract available


  32. ALTUNDAG K
    Late relapse rates in patients with early-stage hormone receptor-positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy.
    J Surg Oncol. 2020 Feb 17. doi: 10.1002/jso.25857.
    PubMed    


  33. BURKBAUER L, Goldbach M, Pomponio M, Tchou J, et al
    Response to "Late relapse rates in patients with early-stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy".
    J Surg Oncol. 2020 Feb 17. doi: 10.1002/jso.25867.
    PubMed    


    January 2020
  34. WANG K, Dai Y, Pan Y, Cheng P, et al
    Local-regional recurrence risk after autologous fat grafting in breast cancer patients: A systematic review and meta-analysis.
    J Surg Oncol. 2020 Jan 14. doi: 10.1002/jso.25829.
    PubMed     Abstract available


  35. POMPONIO MK, Burkbauer L, Goldbach M, Nazarian SM, et al
    Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.
    J Surg Oncol. 2020 Jan 9. doi: 10.1002/jso.25814.
    PubMed     Abstract available


    December 2019
  36. KANDA MH, da Costa Vieira RA, Lima JPSN, Paiva CE, et al
    Late locoregional complications associated with adjuvant radiotherapy in the treatment of breast cancer: Systematic review and meta-analysis.
    J Surg Oncol. 2019 Dec 26. doi: 10.1002/jso.25820.
    PubMed     Abstract available


  37. ROY M, Sebastiampillai S, Haykal S, Zhong T, et al
    Development and validation of a risk stratification model for immediate microvascular breast reconstruction.
    J Surg Oncol. 2019;120:1177-1183.
    PubMed     Abstract available


  38. TARUNO K, Kurita T, Kuwahata A, Yanagihara K, et al
    Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe.
    J Surg Oncol. 2019;120:1391-1396.
    PubMed     Abstract available


    November 2019
  39. EAGLEHOUSE YL, Georg MW, Jatoi I, Shriver CD, et al
    Factors related to re-excision procedures following primary breast-conserving surgery for women with breast cancer in the U.S. Military Health System.
    J Surg Oncol. 2019 Nov 29. doi: 10.1002/jso.25788.
    PubMed     Abstract available


  40. LIN JY, Yang X, Serra M, Miller AH, et al
    Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer.
    J Surg Oncol. 2019 Nov 8. doi: 10.1002/jso.25757.
    PubMed     Abstract available


  41. DIONYSSIOU D, Demiri E, Sarafis A, Goula CO, et al
    Functional lymphatic reconstruction with the "Selected Lymph Node" technique guided by a SPECT-CT lymphoscintigraphy.
    J Surg Oncol. 2019;120:911-918.
    PubMed     Abstract available


    September 2019
  42. RATTI F, Serenari M, Zanello M, Prosperi E, et al
    Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases.
    J Surg Oncol. 2019 Sep 9. doi: 10.1002/jso.25702.
    PubMed     Abstract available


  43. ZHOU L, Wang Y, Cai R, Huang J, et al
    Pedicled descending branch latissimus dorsi mini-flap in repairing partial mastectomy defect: Shoulder functional and esthetic outcomes.
    J Surg Oncol. 2019;120:518-526.
    PubMed     Abstract available


  44. EBNER PJ, Liu A, Gould DJ, Patel KM, et al
    Breast implant-associated anaplastic large cell lymphoma, a systematic review and in-depth evaluation of the current understanding.
    J Surg Oncol. 2019;120:573-577.
    PubMed     Abstract available


  45. MURPHY BL, Thiels CA, Hanson KT, McLaughlin S, et al
    Pain and opioid prescriptions vary by procedure after breast surgery.
    J Surg Oncol. 2019;120:593-602.
    PubMed     Abstract available


  46. FAYANJU OM, Williamson HV
    Response to Letter to the Editor: "The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma".
    J Surg Oncol. 2019;120:566.
    PubMed    


  47. ALTUNDAG K
    Patients with invasive lobular and ductal carcinoma or pleomorphic lobular carcinoma might increase pathologic complete response rate and lower mastectomy rates compared to classical lobular type.
    J Surg Oncol. 2019;120:565.
    PubMed    


    August 2019
  48. SANTIAGO L, Adrada BE, Caudle AS, Clemens MW, et al
    The role of three-dimensional printing in the surgical management of breast cancer.
    J Surg Oncol. 2019 Aug 22. doi: 10.1002/jso.25680.
    PubMed     Abstract available


  49. SENER SF, Sargent RE, Lee C, Manchandia T, et al
    MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer.
    J Surg Oncol. 2019 Aug 9. doi: 10.1002/jso.25663.
    PubMed     Abstract available


  50. SCHWARZ GS, Grobmyer SR, Djohan RS, Cakmakoglu C, et al
    Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow.
    J Surg Oncol. 2019;120:160-167.
    PubMed     Abstract available


  51. KRAENZLIN FS, Saunders H, Aliu O, Cooney D, et al
    Classification of breast tissue expander infections: Back to the basics.
    J Surg Oncol. 2019;120:142-147.
    PubMed     Abstract available


  52. TAMIRISA N, Williamson HV, Thomas SM, Westbrook KE, et al
    The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.
    J Surg Oncol. 2019;120:132-141.
    PubMed     Abstract available


    July 2019
  53. VAN DEN HOVEN I, van Klaveren D, Verheuvel NC, van la Parra RFD, et al
    Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool.
    J Surg Oncol. 2019 Jul 23. doi: 10.1002/jso.25644.
    PubMed     Abstract available


  54. MOUSAVI SR, Akbari ME, Zarrintan S
    Vascularized gastroepiploic lymph node transfer significantly improves breast cancer-related lymphedema.
    J Surg Oncol. 2019 Jul 16. doi: 10.1002/jso.25607.
    PubMed     Abstract available


  55. HOUPU Y, Fei X, Yang Y, Fuzhong T, et al
    Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer.
    J Surg Oncol. 2019 Jul 16. doi: 10.1002/jso.25638.
    PubMed     Abstract available


  56. LEE TC, Reyna C, Shaughnessy E, Lewis JD, et al
    Screening of populations at high risk for breast cancer.
    J Surg Oncol. 2019 Jul 8. doi: 10.1002/jso.25611.
    PubMed     Abstract available


    June 2019
  57. SENER SF
    Advances in axillary surgery for breast cancer 2019.
    J Surg Oncol. 2019 Jun 25. doi: 10.1002/jso.25591.
    PubMed     Abstract available


  58. LIN CY, Liu HE, Cheng MH
    Factors associated with professional healthcare advice seeking in breast cancer-related lymphedema.
    J Surg Oncol. 2019 Jun 18. doi: 10.1002/jso.25523.
    PubMed     Abstract available


  59. ZHAO B, Tsai C, Hunt KK, Blair SL, et al
    Adherence to surgical and oncologic standards improves survival in breast cancer patients.
    J Surg Oncol. 2019 Jun 6. doi: 10.1002/jso.25506.
    PubMed     Abstract available


  60. CORSI F, Bossi D, Combi F, Papadopoulou O, et al
    Radio-guided vs clip-guided localization of nonpalpable mass-like lesions of the breast from a screened population: A propensity score-matched study.
    J Surg Oncol. 2019;119:916-924.
    PubMed     Abstract available


  61. CHAUDHRY A, Oliver JD, Vyas KS, Alsubaie SA, et al
    Outcomes analysis of Goldilocks mastectomy and breast reconstruction: A single institution experience of 96 cases.
    J Surg Oncol. 2019;119:1047-1052.
    PubMed     Abstract available


    May 2019
  62. BRUENDERMAN EH, Bhutiani N, Mercer MK, McMasters KM, et al
    Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery.
    J Surg Oncol. 2019;119:694-699.
    PubMed     Abstract available


    March 2019
  63. ZHONG W, Tan L, Jiang WG, Chen K, et al
    Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis.
    J Surg Oncol. 2019 Mar 20. doi: 10.1002/jso.25457.
    PubMed     Abstract available


  64. VIEIRA RAC, Boni RADS, Silva VD
    Reply: ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall based on a systematic review of thoracoabdominal flaps.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25436.
    PubMed    


  65. BURATTINI ACB, Horacio GS, Beloti TR
    Reply: ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall, based on a systematic review of thoracoabdominal flaps.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25439.
    PubMed    


  66. TAN MG, Isaranuwatchai W, DeLyzer T, Butler K, et al
    A cost-effectiveness analysis of DIEP vs free MS-TRAM flap for microsurgical breast reconstruction.
    J Surg Oncol. 2019;119:388-396.
    PubMed     Abstract available


  67. BANKS A, Coronado G, Zimmerman R, Iyengar G, et al
    Breast conserving surgery with targeted intraoperative radiotherapy for the management of ductal carcinoma in situ.
    J Surg Oncol. 2019;119:409-420.
    PubMed     Abstract available


    February 2019
  68. PARK KU, Kyrish K, Terrell J, Yi M, et al
    Surgeon perception versus reality: Opioid use after breast cancer surgery.
    J Surg Oncol. 2019 Feb 8. doi: 10.1002/jso.25395.
    PubMed     Abstract available


    January 2019
  69. DASGUPTA H, Islam S, Alam N, Roy A, et al
    Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance.
    J Surg Oncol. 2019;119:88-100.
    PubMed     Abstract available


    December 2018
  70. HELLINGMAN D, de Wit-van der Veen BJ, Wan OY, van der Ploeg IM, et al
    Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25339.
    PubMed     Abstract available


  71. LAWS A, Brar MS, Bouchard-Fortier A, Leong B, et al
    Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
    J Surg Oncol. 2018;118:1205-1211.
    PubMed     Abstract available


  72. JIN L, Wu X, Zha L, Feng Y, et al
    Adjacent skin rotation flap for large defect in primary breast tumor.
    J Surg Oncol. 2018;118:1199-1204.
    PubMed     Abstract available


    November 2018
  73. BERGER ER, Bilimoria KY, Kinnier CV, Minami CA, et al
    Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25294.
    PubMed     Abstract available


  74. PANCHAL H, Pilewskie ML, Sheckter CC, Albornoz CR, et al
    National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25315.
    PubMed     Abstract available


  75. YU TJ, Liu YY, Hu X, Di GH, et al
    No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma.
    J Surg Oncol. 2018;118:928-935.
    PubMed     Abstract available


  76. OLASEHINDE O, Alatise O, Arowolo O, Adisa A, et al
    Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.
    J Surg Oncol. 2018;118:861-866.
    PubMed     Abstract available


  77. XU F, Sun H, Zhang C, Jiang H, et al
    Comparison of surgical complication between immediate implant and autologous breast reconstruction after mastectomy: A multicenter study of 426 cases.
    J Surg Oncol. 2018;118:953-958.
    PubMed     Abstract available


  78. MAY M, Chin C, Hirji S, Horowitz D, et al
    Comparing preoperative imaging modalities in patient selection for breast intraoperative radiotherapy.
    J Surg Oncol. 2018;118:959-965.
    PubMed     Abstract available


    October 2018
  79. JOHNSON AR, Singhal D
    Immediate lymphatic reconstruction.
    J Surg Oncol. 2018;118:750-757.
    PubMed     Abstract available


    September 2018
  80. BEAR HD, Wan W, Robidoux A, Rubin P, et al
    Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.
    J Surg Oncol. 2018;118:722.
    PubMed    


  81. HO OA, Lin YL, Pappalardo M, Cheng MH, et al
    Nipple-sparing mastectomy and breast reconstruction with a deep inferior epigastric perforator flap using thoracodorsal recipient vessels and a low lateral incision.
    J Surg Oncol. 2018;118:621-629.
    PubMed     Abstract available


    August 2018
  82. OHASHI R, Namimatsu S, Sakatani T, Naito Z, et al
    Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3.
    J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25152.
    PubMed     Abstract available


    July 2018
  83. SUSNIK B, Schneider L, Swenson KK, Krueger J, et al
    Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
    J Surg Oncol. 2018;118:221-227.
    PubMed     Abstract available


  84. YOON-FLANNERY K, DeStefano LM, De La Cruz LM, Fisher CS, et al
    Quality of life and sexual well-being after nipple sparing mastectomy: A matched comparison of patients using the breast Q.
    J Surg Oncol. 2018;118:238-242.
    PubMed     Abstract available


  85. SMITH JR, Jaffe J, Pruitt J, Yao K, et al
    The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis.
    J Surg Oncol. 2018;118:212-220.
    PubMed     Abstract available


    June 2018
  86. FUJIMOTO Y, Higuchi T, Nishimukai A, Miyagawa Y, et al
    High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25125.
    PubMed     Abstract available


  87. ROSTAS JW, Bhutiani N, Crigger M, Crawford SMW, et al
    Calculation of breast volumes from mammogram: Comparison of four separate equations relative to mastectomy specimen volumes.
    J Surg Oncol. 2018;117:1848-1853.
    PubMed     Abstract available


    May 2018
  88. SHEN S, Xu Q, Zhou Y, Mao F, et al
    Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer.
    J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25058.
    PubMed     Abstract available


    April 2018
  89. VOLDERS JH, Negenborn VL, Haloua MH, Krekel NMA, et al
    Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.
    J Surg Oncol. 2018;117:1001-1008.
    PubMed     Abstract available


    March 2018
  90. ALTUNDAG K
    Breast cancer subtypes and local recurrence rate after surgery for bone metastasis to the extremities.
    J Surg Oncol. 2018 Mar 30. doi: 10.1002/jso.24987.
    PubMed    


  91. FOSTER D, Choy N, Porter C, Ahmed S, et al
    Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    J Surg Oncol. 2018;117:336-340.
    PubMed     Abstract available


  92. SO A, De La Cruz LM, Williams AD, Bahng J, et al
    The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
    J Surg Oncol. 2018;117:558-566.
    PubMed     Abstract available


    February 2018
  93. PERCY DB, Pao JS, McKevitt E, Dingee C, et al
    Number of nodes in sentinel lymph node biopsy for breast cancer: Are surgeons still biased?
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25010.
    PubMed     Abstract available


    December 2017
  94. GERVAIS MK, Burtenshaw SM, Maxwell J, Dickson BC, et al
    Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges.
    J Surg Oncol. 2017;116:1056-1061.
    PubMed     Abstract available


  95. GIANNINI V, Bianchi V, Carabalona S, Mazzetti S, et al
    MRI to predict nipple-areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor.
    J Surg Oncol. 2017;116:1069-1078.
    PubMed     Abstract available


  96. ALVARADO M, Lucci A, Manders J
    Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice.
    J Surg Oncol. 2017;116:1016-1020.
    PubMed     Abstract available


  97. PATTEN CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, et al
    Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice.
    J Surg Oncol. 2017;116:1040-1045.
    PubMed     Abstract available


  98. HWANG H, Park S, Koo JS, Park HS, et al
    Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.
    J Surg Oncol. 2017;116:1046-1055.
    PubMed     Abstract available


    November 2017
  99. TATARA T, Mukohara T, Shimono Y, Yamasaki T, et al
    Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24937.
    PubMed     Abstract available


  100. ONEGA T, Weiss JE, Goodrich ME, Zhu W, et al
    Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24796.
    PubMed     Abstract available


    October 2017
  101. LEE S, Jung Y, Bae Y
    Immediate chest wall reconstruction using an external oblique myocutaneous flap for large skin defects after mastectomy in advanced or recurrent breast cancer patients: A single center experience.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24830.
    PubMed     Abstract available


  102. ALTUNDAG K
    Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients?
    J Surg Oncol. 2017 Oct 2. doi: 10.1002/jso.24839.
    PubMed    


    September 2017
  103. NOGUCHI M, Ohno Y, Morioka E, Noguchi M, et al
    A novel oncoplastic technique for breast cancer localized in the lower pole of the breast.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24824.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: